Literature DB >> 32700220

Peer Support for Self-Management of Chronic Pain: the Evaluation of a Peer Coach-Led Intervention to Improve Pain Symptoms (ECLIPSE) Trial.

Marianne S Matthias1,2,3, Matthew J Bair4,5,6, Susan Ofner7, Michele Heisler8,9, Marina Kukla4,10, Alan B McGuire4,10, Jasma Adams4, Carol Kempf4,6, Emilee Pierce4,5, Tetla Menen4, Stephanie McCalley4, Nicole L Johnson4, Joanne Daggy7.   

Abstract

BACKGROUND: Pain self-management is an effective, evidence-based treatment for chronic pain. Peer support, in which patients serve as coaches for other patients, has been effective in other chronic conditions and is a potentially promising approach to implementing pain self-management programs using fewer clinical resources.
OBJECTIVE: To test a peer coach-delivered pain self-management program for chronic pain.
DESIGN: Randomized controlled trial. PARTICIPANTS: Veterans with chronic musculoskeletal pain. INTERVENTION: Intervention patients were assigned a trained peer coach for 6 months. Coaches, who were volunteers, were asked to contact their assigned patients, either by phone or in person, twice per month. Coaches and patients were given an intervention manual to guide sessions. The control group was offered a 2-hour pain self-management class. MAIN MEASURES: The primary outcome was total pain, assessed by the Brief Pain Inventory (BPI). Secondary outcomes were anxiety, depression, pain catastrophizing, self-efficacy, social support, patient activation, health-related quality of life, and healthcare utilization. Outcomes were measured at baseline, 6 months, and 9 months. KEY
RESULTS: Two hundred fifteen patients enrolled (120 intervention, 95 control). Adherence to intervention protocol was low, with only 13% of patients reporting having at least the recommended 12 peer coach meetings over the 6-month intervention. BPI total decreased from baseline to 6 months and baseline to 9 months in both groups. At 9 months, this change was statistically significant (intervention, - 0.40, p = 0.018; control, - 0.47, p = 0.006). There was not a statistically significant difference between groups on BPI at either time point. No secondary outcomes improved significantly in either group after adjusting for multiple comparisons.
CONCLUSIONS: Patients randomized to peer support did not differ from control patients on primary and secondary outcomes. Other peer support models that do not rely on volunteers might be more effective. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02380690.

Entities:  

Keywords:  ECLIPSE; chronic pain; pain self-management; peer support

Mesh:

Year:  2020        PMID: 32700220      PMCID: PMC7728830          DOI: 10.1007/s11606-020-06007-6

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  4 in total

1.  Coordination of Care Between Chiropractic and Behavioral Health Practitioners Within the US Department of Veterans Affairs Health Care System: A Report of 3 Patients With Pain and Mental Health Symptoms.

Authors:  Clinton J Daniels; Derek R Anderson; Zachary A Cupler
Journal:  J Chiropr Med       Date:  2022-03-16

Review 2.  Adherence to and the Maintenance of Self-Management Behaviour in Older People with Musculoskeletal Pain-A Scoping Review and Theoretical Models.

Authors:  Anne Söderlund; Petra von Heideken Wågert
Journal:  J Clin Med       Date:  2021-01-15       Impact factor: 4.241

3.  Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis.

Authors:  Nicholas Avery; Amy G McNeilage; Fiona Stanaway; Claire E Ashton-James; Fiona M Blyth; Rebecca Martin; Ali Gholamrezaei; Paul Glare
Journal:  BMJ       Date:  2022-04-04

4.  Protocol for a pragmatic feasibility randomised controlled trial of peer coaching for adults with long-term conditions: PEER CONNECT.

Authors:  Rachel Dennett; Tom Thompson; Wendy Clyne; Agne Straukiene; Helen Davies-Cox; Joanne Hosking; Krystina Bones; Olivia Weight; Julian Elston
Journal:  BMJ Open       Date:  2022-09-29       Impact factor: 3.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.